Cargando…
Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case report
Gemcitabine is frequently used for the treatment of a number of different cancer types. Gemcitabine-related thrombotic microangiopathy (TMA) has rarely been described, but it is a life-threatening complication. The incidence of the complication varies between 0.015 and 1.4%. The present study report...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403528/ https://www.ncbi.nlm.nih.gov/pubmed/28454234 http://dx.doi.org/10.3892/ol.2017.5576 |